As of Jun 26
| -0.05 / -2.50%|
The 1 analysts offering 12-month price forecasts for MusclePharm Corp have a median target of 4.00, with a high estimate of 4.00 and a low estimate of 4.00. The median estimate represents a +105.13% increase from the last price of 1.95.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.